Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2026-01-22 @ 1:29 PM
Study NCT ID:
NCT03767751
Status:
UNKNOWN
Last Update Posted:
2018-12-07
First Post:
2018-12-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Feasibility and Safety Study of Dual Specificity CD38 and BCMA CAR-T Cell Immunotherapy for Relapsed or Refractory Multiple Myeloma
Sponsor:
Chinese PLA General Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Multiple Myeloma | View |
Keywords: